Sequelae of hypoxic-ischemic encephalopathy
Apr 14, 2022
Source: Cainiu Health
Dr. Li Qi
Introduction
The primary causes of sequelae following hypoxic-ischemic encephalopathy (HIE) are intrauterine asphyxia and perinatal asphyxia, both of which result in brain injury. HIE predominantly affects a child’s level of consciousness and muscle tone. Its sequelae are broadly categorized into short-term and long-term complications. The longer the duration of hypoxia, the higher the likelihood and severity of cerebral palsy and other sequelae. Short-term sequelae often include immediate death.
Today, many children develop hypoxic-ischemic encephalopathy (HIE). Prompt treatment is essential upon diagnosis to prevent long-term complications. What are the underlying causes of HIE sequelae?
What Causes the Sequelae of Hypoxic-Ischemic Encephalopathy?
The primary causes of HIE sequelae are intrauterine asphyxia and perinatal asphyxia, both leading to cerebral injury. These conditions predominantly affect a child’s level of consciousness and muscle tone. The resulting sequelae fall into two categories: short-term and long-term. Prolonged hypoxia significantly increases the risk and severity of cerebral palsy. Short-term sequelae often include immediate mortality, whereas long-term sequelae primarily involve disturbances in consciousness and damage to brain tissue—potentially resulting in delayed intellectual development, decreased muscle tone, poor responsiveness, cerebral palsy, epilepsy, and other neurological impairments.
Hypoxic-ischemic encephalopathy does not resolve spontaneously and requires medical intervention. It is closely associated with cerebral arteriosclerosis, which reduces cerebral blood flow. If left untreated or uncontrolled, the condition may progress to cerebral atrophy and cognitive decline. Therefore, timely intervention is crucial. Patients are advised to take medications that improve cerebral circulation, such as Ginkgo Ketone Ester Dropping Pills, Xuesaitong Tablets, and Zheshetongluo Capsules.
Additionally, pharmacological management of risk factors for cerebral arterial disease—including hypertension, dyslipidemia, and elevated homocysteine—is recommended. Dietary modifications should emphasize low-salt, low-fat, and light meals. Aspirin may be prescribed to inhibit platelet aggregation and prevent thrombosis, thereby alleviating symptoms such as dizziness. We hope this information proves helpful.
